Cygnet.One strengthens global e-Invoicing capabilities with expanded accreditations and enhanced support for Malaysia’s LHDN & MDEC framework
Smmwiz Highlights Infrastructure Maturity as the SMM Panel Industry Evolves in 2026
Enhancing the Front Door of Business Messaging
HKTDC’s response to World Trade Organization’s latest report
The Full Spectrum of K-Culture in One Place: “2026 MyK FESTA” to Open June 25
SOUTH SAN FRANCISCO, Calif., March 09, 2022 (GLOBE NEWSWIRE) — Frontier Medicines Corporation, a precision…
TORONTO and CHICAGO, March 09, 2022 (GLOBE NEWSWIRE) — Medexus Pharmaceuticals Inc. (“Medexus” or the…
CAMARILLO, Calif., March 09, 2022 (GLOBE NEWSWIRE) — Dyve Biosciences, Inc. (“Dyve”), a clinical-stage biotech…
REDWOOD CITY, Calif., March 09, 2022 (GLOBE NEWSWIRE) — Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO),…
FLORHAM PARK, N.J., March 09, 2022 (GLOBE NEWSWIRE) — PDS Biotechnology Corporation (Nasdaq: PDSB), a…
WORCESTER, Mass., March 09, 2022 (GLOBE NEWSWIRE) — Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO), a…
WATERTOWN, Mass., March 09, 2022 (GLOBE NEWSWIRE) — C4 Therapeutics, Inc. (C4T) (Nasdaq: CCCC), a…
WILMINGTON, Del., March 09, 2022 (GLOBE NEWSWIRE) — Prelude Therapeutics Incorporated (Nasdaq: PRLD) a clinical-stage…
SOUTH SAN FRANCISCO, Calif., March 09, 2022 (GLOBE NEWSWIRE) — Denali Therapeutics Inc. (NASDAQ: DNLI),…
CAMBRIDGE, Mass., March 09, 2022 (GLOBE NEWSWIRE) — Cullinan Oncology, Inc. (Nasdaq: CGEM) (“Cullinan”), a biopharmaceutical…
Data to be presented at the 2022 annual meeting of American Association for Cancer Research…
On track to complete dosing of the first cohort and share initial data by the…
Broad-acting antihistamine has potential in number of disease areas with unmet clinical need NEW YORK…
OCALA, Fla., March 09, 2022 (GLOBE NEWSWIRE) — AIM ImmunoTech Inc. (NYSE: American AIM) (“AIM”…
Pipeline of Development-Stage RAS(ON) Inhibitors to be Highlighted in Four Presentations in “Targeting the RAS…
MALVERN, Pa., March 09, 2022 (GLOBE NEWSWIRE) — Ocugen, Inc. (NASDAQ: OCGN), a clinical-stage biopharmaceutical…
OCALA, Fla., March 09, 2022 (GLOBE NEWSWIRE) — AIM ImmunoTech Inc. (NYSE: American AIM) (“AIM”…
The acquisition adds newly developed, advanced software that identifies and protects IBM i and Linux…
Alliance simplifies lifecycle management of thousands of users and machine identities across the enterprise SANTA…
The school safety and dismissal platform continues growth with the addition of its safety panic…